Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.
about
Nutritional assessment in cirrhotic patients with hepatic encephalopathyTreating morbid obesity in cirrhosis: A quest of holy grailBariatric Surgery and Liver TransplantationNutrition and exercise in the management of liver cirrhosisChanges in nutritional status after liver transplantationObesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients.Statin use in patients with cirrhosis: a retrospective cohort study.Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical TrialEffect of obstructive sleep apnea on the sleep architecture in cirrhosis.Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival.Role of magnetic resonance elastography in compensated and decompensated liver disease.New therapeutic paradigm for patients with cirrhosis.Future treatments of cirrhosis.A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis.The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Lower values of handgrip strength and adductor pollicis muscle thickness are associated with hepatic encephalopathy manifestations in cirrhotic patients.Monitoring of Liver Function Tests after Roux-en-Y Gastric Bypass: An Examination of Evidence Base.A practical approach to nutritional screening and assessment in cirrhosis.Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study.Adipokines in Liver Cirrhosis.Diagnostic hepatic haemodynamic techniques: safety and radiation exposure.Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis.Spontaneous bacterial peritonitis is a risk factor for renal failure requiring dialysis in waitlisted liver transplant candidates.ASSOCIATION OF THE NUTRITIONAL PROFILE WITH HISTOLOGICAL FINDINGS OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION.Obesity is independently associated with infection in hospitalised patients with end-stage liver disease.The impact of obesity in cirrhotic patients with septic shock: a retrospective cohort study.Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats.Compensated cirrhosis, same outcomes no matter which continent.Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction.Advances and challenges in cirrhosis and portal hypertension.Weight loss interventions for morbidly obese patients with compensated cirrhosis: a Markov decision analysis model.Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation.Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.Pharmacologic prevention of variceal bleeding and rebleeding.The portal hypertension syndrome: etiology, classification, relevance, and animal models.Hepatic encephalopathy in patients in Lviv (Ukraine)
P2860
Q26771155-43778F9C-D63F-4734-9F1F-E130B8A88BF1Q26775811-9ABC7252-D102-4BFE-9011-0BB0CFADABD7Q33711409-179F1A40-CB83-4826-8297-C3E468A19CFEQ33780141-BC0DE2BA-4CC4-43A3-B7B1-89B26F26CFC9Q34067831-1E044BEA-7360-48C5-9C62-6B040F294DFFQ34386690-00AF796E-1AE7-47F6-B958-1E70F09E202FQ34661975-A5AEE630-B226-4C9B-901F-81C164BF4D44Q35969410-8698AF67-FD13-4DEE-8213-CAEC6B66DE6FQ36627779-0FDF7B0E-F1A3-4631-ABEA-EDD28392D56AQ36892959-18A22A0B-939F-4753-89B8-35B3CDD5D244Q37704369-617457A8-8530-4FEA-A253-B09B6E92B148Q37716891-824EEF58-2DD1-4E44-94C2-D90A966C2F30Q38021413-DB779C8B-7E51-4DF7-A5D2-62D1798E4A6EQ38218607-17451162-565F-410C-A26A-B4759F06CAC1Q38486321-F353234C-8584-4DA8-B5AA-3E4C39AAC49EQ38656970-A9CCB592-C84E-4AA5-8CEB-CDCF5B5CA7A6Q38676257-9219C086-25FC-403A-AE29-7FB81D04C0B2Q38883833-816C1C55-2BA1-4CCE-98A2-7B02F4553171Q38887238-812AC668-8121-44A5-BD8D-B662C5E92373Q39058937-A11A7ABD-4F59-4671-B92D-9C42FB4C7B47Q39082512-7F8B7974-4F9D-4C6B-9C6B-B43955E96FD2Q39404643-C812B613-0E62-441A-9AB9-06F26358FECDQ39519847-7108F337-22AA-433B-8695-798920454BBBQ39870366-22FFBD50-2786-48F6-8F32-13E3EAF45D0FQ40015439-47F46D30-3C37-4353-9A43-56D38C930D1CQ40807182-1F3AF56F-6A30-4131-8356-62167B28642CQ40933907-A4A5CBE9-F57F-46FF-AE27-79A894484BE8Q44877545-45AFE601-FAAB-4133-81B6-037A545889F1Q45092997-9C43EBE5-0BD0-4B22-ACA3-DDF34D98742BQ46205910-6E01438B-FDDF-407B-AD41-79E0203A9CEAQ46517321-07B9D53A-F27A-4A30-A906-BC440F098ECCQ47095006-DAAA8048-3752-4A27-97BC-AF78A25D0AE1Q47218598-A353035D-6919-421D-9918-7EA945214D5AQ48232083-AFDCD939-20F8-4E23-8EE5-E3F068617A68Q48269557-8D7870B0-DC00-4081-A6CB-B8F0DE29A79DQ48276992-ECDE90A9-5012-4DF6-993C-50C21EB5B434Q50054841-388CE64A-871F-4C54-B1AD-7FC082CD53DCQ50075138-3026AEF3-CBE8-433F-B805-04BAFC630ED5Q58695674-16B96334-62FA-428C-AACC-7CE2F72D518E
P2860
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Obesity is an independent risk ...... on in patients with cirrhosis.
@ast
Obesity is an independent risk ...... on in patients with cirrhosis.
@en
type
label
Obesity is an independent risk ...... on in patients with cirrhosis.
@ast
Obesity is an independent risk ...... on in patients with cirrhosis.
@en
prefLabel
Obesity is an independent risk ...... on in patients with cirrhosis.
@ast
Obesity is an independent risk ...... on in patients with cirrhosis.
@en
P2093
P2860
P356
P1433
P1476
Obesity is an independent risk ...... on in patients with cirrhosis.
@en
P2093
Angels Escorsell
Annalisa Berzigotti
Daniel S Matloff
David Patch
Guadalupe Garcia-Tsao
Jaime Bosch
Norman D Grace
Portal Hypertension Collaborative Group
Roberto J Groszmann
Rosa Morillas
P2860
P304
P356
10.1002/HEP.24418
P407
P577
2011-06-26T00:00:00Z